Previously, Templeman was general manager of Centocor Biologics, an operating company of Johnson & Johnson and manufacturing site.
Liquidia, spun out of UNC Chapel Hill and founded in 2004, develops rationally designed nanoparticles for delivery of small molecule and biological agents to enable breakthroughs in vaccines, inhaled therapeutics, and siRNA-based therapeutics.
To see more of The Herald-Sun, or to subscribe to the newspaper, go to http://www.herald-sun.com. Copyright (c) 2009, The Herald-Sun, Durham, N.C. Distributed by McClatchy-Tribune Information Services. For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index